Specialty Pharmacy

InfuCare Rx is committed to providing unparalleled clinical services to patients with complex conditions such as Multiple Sclerosis and Hepatitis C.

Reimbursement

Our experienced team provides assistance with prior authorization requirements, as well as appeal support. We help connect patients with financial and copay assistance resources to reduce the financial burden that patients may feel when dealing with a chronic condition.



Education

Highly trained and skilled pharmacists are available 24/7. We connect patients with advocacy groups that offer emotional support and clinical education and counseling for their specific disease state or therapy. Our team members help remove barriers to care, so patients are better able to adhere to their therapy regimen which, in turn, results in better clinical outcomes.



Support

We assist patients, physicians and other health care providers with the entire process of referring and treating patients. Along with providing fast, reliable services, we offer side effect management and patient education on treatments and conditions. Our refill reminder services improves patient adherence, which enables patients to get the most out of their doctor prescribed treatment regimens.




What is multiple sclerosis?

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. The central nervous system is made up of the brain, spinal cord and optic nerves. A fatty tissue called myelin surrounds and protects the nerve fibers of the central nervous system which helps nerve fibers conduct electrical impulses throughout the body. In MS, the myelin is damaged in many areas, causing plaques or lesions and ultimately scar tissue to develop. As a result sclerosis occurs, and the ability of the nerves to conduct electrical impulses and the flow of information within the brain, and between the brain and body is disrupted.

MS affects approximately 250,000 to 350,000 people in the United States. Most people experience their first symptoms between the ages of 20 and 40 years old. Women are two times more likely to develop MS than men. Whites are the most likely to develop MS, with the disease being five times more prevalent in regions with mild temperatures over tropical regions.

There are four different disease courses in MS. They are referred to as Relapsing Remitting (Relapsing Remitting MS), Primary Progressive (Primary Progressive MS), Secondary Progressive (Secondary Progressive MS) and Progressive-Relapsing (Progressive-Relapsing MS). The most common disease course is relapsing-remitting MS. Approximately 85% of people with MS are initially diagnosed with this course of MS. About 20 percent of the MS population has a benign form of the disease where there is little to no progression of symptoms after the initial attack and patients remain functional.

What causes multiple sclerosis?

Although scientists have learned a great deal about MS in recent years, the exact cause of MS is still unknown. Many investigators believe that the damage to the myelin occurs as a result of an abnormal response by the body’s immune system. This abnormal response launches the body into a defensive attack against its own tissues. Most agree that this autoimmune attack is a result of different factors, including unidentified environmental factors in a person who is genetically predisposed to respond.

Treatment of multiple sclerosis

There is no cure for MS; however, there are many medications available to help manage the disease on an ongoing basis. The goals of therapy are to improve recovery from attacks, to prevent or lessen the number of relapses and to stop the disease from progressing.

There are many resources and organizations available to provide assistance, support, advocacy and information:

National Multiple Sclerosis Society

Multiple Sclerosis Foundation

Multiple Sclerosis Association of America

What is Hepatitis C?

Hepatitis C is a contagious liver disease resulting from infection caused by the hepatitis C virus. It’s severity can range from a mild illness lasting only a few weeks to a lifelong, serious illness that attacks the liver and leads to inflammation.

Approximately 3.2 million people in the United States have the chronic form of hepatitis C, and about 17,000 Americans become infected with hepatitis C each year.

Treatment of hepatitis C

Hepatitis C is not treated unless it becomes chronic. Treatment often includes taking combinations of different antiviral medications that help to fight the hepatitis C virus.

There are many resources and organizations available to provide assistance, support, advocacy and information:

American Liver Foundation

Hepatitis Foundation International

Hepatitis C Association

Contact Us!

Our Specialty Pharmacy

Get in touch today to learn more about our Specialty Pharmacy


We coordinate every step of the process, working closely with physicians, insurance companies and pharmaceutical manufacturers to optimize treatment outcomes for our patients. We are proud to back these claims with unparalleled patient and prescriber satisfaction.